BASIS Medical Technologies commercializes and distributes innovative technologies in medical aesthetics globally. Among our technologies, BASIS is the international market representative for Lumixyl™, a revolutionary peptide technology out of Stanford University that offers a non-irritating, effective and safe alternative to Hydroquinone. BASIS is pleased to make the full Lumixyl™ Brightening System available in the UK in cooperation with Wigmore Medical.

For more details contact Wigmore Medical on: